Trends in the use and outcomes of implantable cardioverter-defibrillators in patients undergoing dialysis in the United States.
about
Evolution of Cardiovascular Disease During the Transition to End-Stage Renal Disease.Prophylactic implantable cardioverter defibrillator in heart failure: the growing evidence for all or Primum non nocere for some?Implantable cardioverter-defibrillators for primary prevention of sudden cardiac death in CKD: a meta-analysis of patient-level data from 3 randomized trials.Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator.Mortality in patients on renal replacement therapy and permanent cardiac pacemakers.Clinical presentation and outcomes of cardiovascular implantable electronic device infections in hemodialysis patients.Outcomes of infected cardiovascular implantable devices in dialysis patients.The interplay between CKD, sudden cardiac death, and ventricular arrhythmiasOutcomes of implantable cardioverter-defibrillator use in patients with comorbidities: results from a combined analysis of 4 randomized clinical trials.Effects of cinacalcet on atherosclerotic and nonatherosclerotic cardiovascular events in patients receiving hemodialysis: the EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events (EVOLVE) trial.Primary prevention implantable cardioverter defibrillators in end-stage kidney disease patients on dialysis: a matched cohort study.CKD and sudden cardiac death: epidemiology, mechanisms, and therapeutic approaches.Inverse relationship between long-chain n-3 fatty acids and risk of sudden cardiac death in patients starting hemodialysis.Evidence-based cardiology in hemodialysis patientsApplication of ICD guidelines and indications in a community-based academic hospital: a case series-based discussion.Sudden cardiac death in hemodialysis patients: a comprehensive care approach to reduce risk.Transvenous cardiac implantable electronic devices and hemodialysis catheters: recommendations to curtail a potentially lethal combination.Cardiovascular implantable electronic device leads in CKD and ESRD patients: review and recommendations for practice.Prevention of sudden cardiac death in patients with chronic kidney disease: risk and benefits of the implantable cardioverter defibrillator.Prevention of sudden cardiac death in dialysis patients: drugs, defibrillators or what else.The impact of transvenous cardiac devices on vascular access patency in hemodialysis patients.Do implantable cardioverter defibrillators improve survival in patients with chronic kidney disease at high risk of sudden cardiac death? A meta-analysis of observational studies.Risk of sudden cardiac death in chronic kidney disease.Adverse events following implantable cardioverter defibrillator implantation: a systematic review.Sudden cardiac death in haemodialysis patients: preventative options.Sudden cardiac death in end stage renal disease: unlocking the mystery.Risk factors for cardiac implantable electronic device infection: a systematic review and meta-analysis.Sudden cardiac death in CKD patients.Cardiovascular complications in chronic dialysis patients.Sudden Cardiac Death Among Hemodialysis Patients.Subcutaneous defibrillators for dialysis patients.Albuminuria, kidney function, and sudden cardiac death: Findings from The Reasons for Geographic and Racial Differences in Stroke (REGARDS) study.Outcome of Subcutaneous Implantable Cardioverter Defibrillator Implantation in Patients with End-Stage Renal Disease on Dialysis.Shades of grey: the conundrum of implantable defibrillators in individuals with advanced CKDDo implantable defibrillators help patients with CKD?The natural history of symptomatic cardiac conduction-system disease in end-stage renal disease.Long-term Outcomes Associated With Implantable Cardioverter Defibrillator in Adults With Chronic Kidney Disease.Cardiovascular implantable electronic devices in hemodialysis patients: prevalence and implications for arteriovenous hemodialysis access interventions.Chronic kidney disease and implantable cardioverter defibrillator related complications: 16 years of experience.Chronic kidney disease and arrhythmias: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
P2860
Q30234797-C906C8D6-D732-4C8A-A4F1-4581579EA706Q30235600-CC268238-1A64-42D8-973A-39EE7004B1FBQ30755342-15B5FFFA-254A-4FF8-B7B5-8A07F03AE82AQ33162850-C7CF7611-D026-419F-BB7C-36CAC8769982Q33757747-3B2DDC3D-048D-42C5-8153-8A75263D11F2Q33801046-F1EB0ED6-EF4A-4800-A60B-CBC59B4B7968Q34437757-A92B4E71-B3AE-4DAF-8195-D208032CD5F6Q34629381-92FF93A2-CF1C-4F51-870D-4103615408DCQ34633191-E2FD1000-E913-4DD7-ABF6-445D52225C6FQ35115090-E9522D2B-0A86-4E7C-B331-E4F93201D933Q35587006-4D4D174E-788A-4C10-8F66-53AE92A9EE02Q36426077-2E4BC31C-4006-476E-8966-22150DE5069FQ36847322-84233070-F8AB-40B6-99C3-223DD24D43BAQ37340239-C8717C34-2735-475E-A76F-17504DCFD64BQ37711369-3E57B80B-CDFD-43E6-9B2E-F682FD3AE195Q37978088-542BF858-C30D-4E8B-BF6C-A53BB2B75CACQ37986891-420264FA-58D5-4E05-A56A-4DFA0D13ECF0Q38034565-A34C9AC0-1B33-4143-B422-1C2369AB9DDCQ38041468-5FF8B686-ABF6-4738-8FEF-BC599466E960Q38076218-F55DEAC8-3F96-4B6A-AF22-124E0B367CFFQ38086282-21512895-65F0-42CA-A035-DA706DCF2401Q38140839-8AC40BD2-FC7C-4CA0-934C-F899E864B4B5Q38164437-1244CD41-B5EB-45BE-A226-8A8D54D008C9Q38221790-D38DAC08-662E-448C-A3B7-C9F4D5D33F54Q38250885-35AD117F-E08E-4B2C-84F2-BBA18027F948Q38267707-6D4007C8-0C4B-4784-B455-ACDD5D6CA712Q38450566-B0E45318-14EF-4A6E-823F-4DBFF718CF96Q38473007-5137739E-BFED-4910-BF01-B184AB8F40ADQ38956399-A5BA3F63-E859-4095-8A39-C6E153D10C11Q39145628-3EDC9824-DF73-4750-8874-3D45CA338CE6Q39393728-86FB4C6C-DBD9-4620-A4A8-311B6BE97E71Q40622509-F9024C95-2667-4960-987C-55E45CD1AA71Q40963736-CE98FBA6-0C24-4273-90B2-8B2222BC301AQ42362485-534FB5D4-C0A9-4AD3-9ADD-DB43ECA38F73Q42767794-24064969-4633-4270-82F6-B38A1BB7D78BQ48047755-FC4F7868-7BEC-4694-AF5F-913D37DAD1BFQ50195020-98B2DB26-D70A-40D1-BD48-DA90C3CD54BEQ53541070-3D6F3C25-3728-42F3-96A9-A8377AAE4A46Q53567784-1027F6F6-5495-46F6-B8A2-66F09573020DQ57750151-DBF7D39C-7088-47CF-83C9-8329E5863415
P2860
Trends in the use and outcomes of implantable cardioverter-defibrillators in patients undergoing dialysis in the United States.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Trends in the use and outcomes ...... dialysis in the United States.
@en
Trends in the use and outcomes ...... dialysis in the United States.
@nl
type
label
Trends in the use and outcomes ...... dialysis in the United States.
@en
Trends in the use and outcomes ...... dialysis in the United States.
@nl
prefLabel
Trends in the use and outcomes ...... dialysis in the United States.
@en
Trends in the use and outcomes ...... dialysis in the United States.
@nl
P2093
P1476
Trends in the use and outcomes ...... dialysis in the United States.
@en
P2093
Amanda R Patrick
Charles A Herzog
David M Charytan
M Alan Brookhart
Soko Setoguchi
Wolfgang C Winkelmayer
P304
P356
10.1053/J.AJKD.2011.03.026
P577
2011-06-12T00:00:00Z